Laura Lande-Diner, PhD

Laura Lande-Diner, PhD, is an experienced biotech entrepreneur and C-suite executive, with a proven track record of co-founding and scaling life sciences companies, driving corporate and clinical strategy, and securing top-tier venture funding resulting in long-term value creation.

As Managing Partner, Laura applies the firm’s unique blend of investment, operational, and scientific expertise, to high-risk, high reward propositions that help unlock innovations that improve lives and shape the future of care.

Prior to Jefferson Life Sciences, she was a founding executive at Satellite Bio, where she served as Chief Business Officer and later as President. Before Satellite, she was a founding team member at Valo Health, where she designed and led the company’s early data strategy and executed four foundational business development partnerships within 18 months of launch.

Laura excels at partnering with scientific founders and executive teams to shape robust IP portfolios, align product pipelines with strategic objectives, and navigate complex regulatory landscapes. Earlier in her career, Laura was part of the Origination team at Flagship Pioneering, where she contributed to the founding of four life sciences companies. In these roles, she helped shape early scientific strategy, develop IP estates, build leadership and advisory teams, and engage the investment community.

Laura earned her PhD in Epigenetics and Molecular Biology from the Hebrew University of Jerusalem Medical School and conducted her postdoctoral research in Circadian Biology at Harvard Medical School, where she later served as an Instructor in Neurobiology. She is a named inventor on numerous patents and applications and has authored multiple peer-reviewed publications. In 2017, she was named one of the 100 Most Inspiring People in the life sciences industry by PharmaVOICE.